Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Sep 14, 2012 · 10-Q · 45 days after period end · 0001554795-12-000077
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$1.09K | -$725.00 | -$731.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jul 31, 2012 · filed Sep 14, 2012 · 45 d after period end
